Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON Block for Migraine Prophylaxis
NCT00915473Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2009
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, methylprednisolone in migraine, sponsored by Mayo Clinic. Started Jun 2009; status: completed.
02
Drugs
bupivacainemethylprednisolone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00915473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915473.